Kayne Anderson MLP Investment Company (KYN) 19.92

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kayne Anderson MLP Investment Company (KYN) 19.92 $KYN

Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at August 31, 2016
BusinessWire - Fri Sep 02, 9:00PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act" as of August 31, 2016.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Announces $50 Million Redemption of its Series G MRP Shares
BusinessWire - Fri Aug 26, 3:50PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) announced that it will redeem all 2,000,000 shares of its Series G Mandatory Redeemable Preferred Shares ("Series G MRP Shares" with an aggregate liquidation preference of $50 million on October 3, 2016.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at July 31, 2016
BusinessWire - Tue Aug 02, 5:20PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act" as of July 31, 2016.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Announces Distribution of $0.55 per Share for Q2 2016
BusinessWire - Thu Jun 23, 7:07PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) announced today its quarterly distribution of $0.55 per share for the quarter ended May 31, 2016.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Has Returned 32.3% Since SmarTrend Recommendation (KYN)
Comtex SmarTrend(R) - Wed Jun 15, 12:47AM CDT
SmarTrend identified an Uptrend for Kayne Anderson MLP Investment (NYSE:KYN) on February 17th, 2016 at $13.91. In approximately 4 months, Kayne Anderson MLP Investment has returned 32.33% as of today's recent price of $18.40.
KYN: 19.92 (+0.09)

Uptrend Call Working As Kayne Anderson MLP Investment Stock Rises 48.9% (KYN)
Comtex SmarTrend(R) - Tue Jun 07, 12:51PM CDT
SmarTrend identified an Uptrend for Kayne Anderson MLP Investment (NYSE:KYN) on February 17th, 2016 at $13.91. In approximately 4 months, Kayne Anderson MLP Investment has returned 48.87% as of today's recent price of $20.70.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at May 31, 2016
BusinessWire - Thu Jun 02, 7:05PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act" as of May 31, 2016.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Up 36.8% Since SmarTrend Uptrend Call (KYN)
Comtex SmarTrend(R) - Tue May 31, 12:46AM CDT
SmarTrend identified an Uptrend for Kayne Anderson MLP Investment (NYSE:KYN) on February 17th, 2016 at $13.91. In approximately 3 months, Kayne Anderson MLP Investment has returned 36.79% as of today's recent price of $19.02.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Has Returned 24.6% Since SmarTrend Recommendation (KYN)
Comtex SmarTrend(R) - Fri May 13, 1:30PM CDT
SmarTrend identified an Uptrend for Kayne Anderson MLP Investment (NYSE:KYN) on February 17th, 2016 at $13.91. In approximately 3 months, Kayne Anderson MLP Investment has returned 24.63% as of today's recent price of $17.33.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at April 30, 2016
BusinessWire - Mon May 02, 8:27PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act" as of April 30, 2016.
KYN: 19.92 (+0.09)

Shares of KYN Up 28.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 28, 1:50PM CDT
SmarTrend identified an Uptrend for Kayne Anderson MLP Investment (NYSE:KYN) on February 17th, 2016 at $13.91. In approximately 2 months, Kayne Anderson MLP Investment has returned 28.95% as of today's recent price of $17.93.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Shares Up 27.3% Since SmarTrend's Buy Recommendation (KYN)
Comtex SmarTrend(R) - Wed Apr 20, 1:36PM CDT
SmarTrend identified an Uptrend for Kayne Anderson MLP Investment (NYSE:KYN) on February 17th, 2016 at $13.91. In approximately 2 months, Kayne Anderson MLP Investment has returned 27.29% as of today's recent price of $17.70.
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at March 31, 2016
BusinessWire - Mon Apr 04, 6:57PM CDT
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act" as of March 31, 2016.
KYN: 19.92 (+0.09)

Here's Why Kayne Anderson MLP Investment Co. Is Slumping Today
Matthew DiLallo, The Motley Fool - Motley Fool - Mon Feb 08, 12:29PM CST
What: Shares of Kayne Anderson MLP Investment were down by more than 11% at 12:45 p.m. ET on Monday. Driving today's weakness was a steep slide in the company's top holdings. So what: Kayne Anderson MLP Investment is a closed-end fund that...
KYN: 19.92 (+0.09)

Kayne Anderson MLP Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at January 31, 2016
BusinessWire - Mon Feb 01, 6:51PM CST
Kayne Anderson MLP Investment Company (the "Company" (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act" as of January 31, 2016.
KYN: 19.92 (+0.09)

Kayne Anderson Announces Tax Characterization of 2015 Distributions for KYN, KYE, KMF and KED
BusinessWire - Fri Jan 29, 6:25PM CST
KA Fund Advisors, LLC ("Kayne Anderson", which serves as the adviser to the following closed-end funds, today announced the tax characterization of 2015 distributions to stockholders.
KYN: 19.92 (+0.09), KMF: 14.82 (+0.23), KYE: 11.23 (+0.07), KED: 18.81 (+0.13)

Kayne Anderson Files 2015 Annual Reports for KYN, KYE, KMF and KED
BusinessWire - Fri Jan 29, 6:25PM CST
KA Fund Advisors, LLC ("Kayne Anderson", which serves as the advisor to Kayne Anderson MLP Investment Company ("KYN", Kayne Anderson Energy Total Return Fund, Inc. ("KYE", Kayne Anderson Midstream/Energy Fund, Inc. ("KMF" and Kayne Anderson Energy Development Company ("KED" announced that copies of each fund's annual report for the year ended November 30, 2015 are available online at www.kaynefunds.com. Hard copies of these reports are available free of charge upon request by calling 1-877-657-3863.
KYN: 19.92 (+0.09), KMF: 14.82 (+0.23), KYE: 11.23 (+0.07), KED: 18.81 (+0.13)

Kayne Anderson MLP Investment Company declares redemption of USD30m series E MRP shares
M2 - Wed Jan 13, 4:47AM CST
Kayne Anderson MLP Investment Company (NYSE:KYN) on Wednesday disclosed the redemption of 1,200,000 shares of its series E mandatory redeemable preferred shares (series E MRP shares), with a total liquidation preference of USD30m, on 12 February 2016.
KYN: 19.92 (+0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kenox Pharmaceuticals Revolutionizes Drug Development Landscape

Updated Category News Views 272

Revolutionizing Drug Development Approaches Kenox Pharmaceuticals Inc, a leading name in the development of innovative Orally Inhaled and Nasal Drug Products (OINDPs), has recently announced an exciting extension of its capabilities. The introduction of small scale non-sterile GMP capabilities marks a significant enhancement to its already comprehensive drug development...

Continue Reading
Exciting Listing of AI-themed ATC Coin on CoinW Exchange

Updated Category News Views 211

Exciting Listing of AI-themed ATC Coin on CoinW Exchange CoinW, recognized as a trailblazer in the realm of cryptocurrency trading platforms, is thrilled to announce the listing of ATC, an innovative meme coin designed around artificial intelligence. ATC will be available for trading in both AI, MEME, and SOL Zones. To celebrate this momentous occasion, which marks an...

Continue Reading
Webstar Technology Group’s Innovative Blockchain Venture

Updated Category News Views 370

Revolutionizing Real Estate with Blockchain Tokenization Webstar Technology Group (OTCMKTS: WBSR) is stepping into the future with a bold initiative that harnesses the power of blockchain technology for real estate ventures. This forward-thinking approach not only highlights the company's commitment to innovation but also positions it as a leader in the rapidly evolving...

Continue Reading
Class Action Lawsuits Update: ATYR, MLTX, BAX, JHX

Updated Category News Views 167

Overview of Recent Class Action Lawsuits Several publicly traded companies are facing legal challenges with class action lawsuits initiated on behalf of their shareholders. It's crucial for investors in these companies to be aware of their rights and the deadlines for potential legal actions. This article discusses the companies involved and provides essential information...

Continue Reading
Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing

Updated Category News Views 164

Partnership Expansion Between Biodesix and Bio-Rad Biodesix, Inc. (NYSE: BDSX), a prominent diagnostics solutions company, has recently strengthened its collaboration with Bio-Rad Laboratories. This expanded partnership focuses on developing and validating advanced in vitro diagnostic assays aimed at enhancing the detection of genomic markers in oncology applications....

Continue Reading